Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Anemia 14Neoplasms 2Uterine Cervical Neoplasms 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Fatigue 1

Interventions

Cyclophosphamide 20fludarabine phosphate 16Busulfan 13Antilymphocyte Serum 13Peripheral Blood Stem Cell Transplantation 12Mycophenolic Acid 12Cyclosporine 11Tacrolimus 9Methylprednisolone 8Filgrastim 8Epoetin Alfa 8Cord Blood Stem Cell Transplantation 7Whole-Body Irradiation 6Radiotherapy 6Methotrexate 6Melphalan 5Etoposide 4Darbepoetin alfa 4Cytarabine 4fludarabine 3Therapeutics 2Immunoenzyme Techniques 2Granulocyte Colony-Stimulating Factor 2Carmustine 2tipifarnib 1sargramostim 1ferrous sulfate 1ferric gluconate 1epoetin beta 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × epoetin beta × Classical hematology × Clear all
NCT00482716 2014-01-10

Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
80 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡